Stock PASG PASSAGE BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Passage Bio, Inc.

Equities

PASG

US7027121000

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-13 pm EDT 		5-day change 1st Jan Change
1.48 USD +0.68% Intraday chart for Passage Bio, Inc. +4.96% +46.53%
Mar. 04 Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 04 Passage Bio, Inc. Appoints Kathleen Borthwick as Chief Financial Officer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PASSAGE BIO, INC. Stock Passage Bio, Inc.
 90.57M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 109B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
ARGENX SE Stock argenx SE
 22.25B -
BIONTECH SE Stock BioNTech SE
 22.09B -
GENMAB A/S Stock Genmab A/S
 18.68B
  1. Stock Market
  2. Equities
  3. PASG Stock
  4. Charts Passage Bio, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW